GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poxel SA (XPAR:POXEL) » Definitions » Operating Cash Flow per Share

Poxel (XPAR:POXEL) Operating Cash Flow per Share : €-0.75 (TTM As of Dec. 2022)


View and export this data going back to 2015. Start your Free Trial

What is Poxel Operating Cash Flow per Share?

Poxel's operating cash flow per share for the six months ended in Dec. 2022 was €-0.29. Poxel's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2022 was €-0.75.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Poxel's Operating Cash Flow per Share or its related term are showing as below:

XPAR:POXEL's 3-Year OCF Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 3.3
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Poxel Operating Cash Flow per Share Historical Data

The historical data trend for Poxel's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poxel Operating Cash Flow per Share Chart

Poxel Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Operating Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.19 -0.99 -0.94 -0.59 -0.75

Poxel Semi-Annual Data
Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.39 -0.56 -0.03 -0.46 -0.29

Competitive Comparison of Poxel's Operating Cash Flow per Share

For the Biotechnology subindustry, Poxel's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Poxel's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Poxel's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Poxel's Price-to-Operating-Cash-Flow falls into.



Poxel Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Poxel's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (A: Dec. 2022 )=Cash Flow from Operations (A: Dec. 2022 )/Shares Outstanding (Diluted Average) (A: Dec. 2022 )
=-21.813/29.077
=-0.75

Poxel's Operating Cash Flow per Share for the quarter that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (Q: Dec. 2022 )=Cash Flow from Operations (Q: Dec. 2022 )/Shares Outstanding (Diluted Average) (Q: Dec. 2022 )
=-8.512/29.222
=-0.29

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Poxel Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Poxel's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Poxel (XPAR:POXEL) Business Description

Industry
Traded in Other Exchanges
Address
259/261 Avenue Jean Jaures, Immeuble le Sunway, Lyon, FRA, 69007
Poxel SA is a biopharmaceutical company. It is focused on the development of novel treatments for metabolic diseases, including type 2 diabetes and liver diseases, such as nonalcoholic steatohepatitis (NASH) and rare disorders (ALD/AMN). It has developed a portfolio of drug candidates, including its candidates: Imeglimin, for the treatment of type 2 diabetes, and PXL770 and PXL065, for the treatment of NASH.

Poxel (XPAR:POXEL) Headlines

No Headlines